Spectrum Management Group, LLC Biogen Inc. Transaction History

Spectrum Management Group, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 03, 2022	SELL	$223.92 - $287.77 $1,791 - $2,302	-8 Closed	0 $0
Q3 2021 Nov 03, 2021	BUY	$282.99 - $369.05 $2,263 - $2,952	8 New	8 $2,000
Q2 2019 Aug 02, 2019	SELL	$219.29 - $241.72 $11,183 - $12,327	-51 Closed	0 $0
Q1 2019 Apr 16, 2019	BUY	$216.71 - $338.96 $11,052 - $17,286	51 New	51 $12,000
Q4 2017 Feb 07, 2018	SELL	$307.64 - $344.58 $32,609 - $36,525	-106 Closed	0 $0
Q3 2017 Nov 07, 2017	BUY	$281.15 - $329.69 $29,801 - $34,947	106	106 $33,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Spectrum Management Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Spectrum Management Group, LLC with notifications on news.